Skip to main content
Black Friday Sale - Get 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Health Canada approval backlog expected to push back arrival of generic Ozempic

Summary by The Globe & Mail
Drugmakers say approvals for generics likely won’t be ready when Ozempic’s market exclusivity ends in January

1 Articles

The Globe & MailThe Globe & Mail
Center

Health Canada approval backlog expected to push back arrival of generic Ozempic

Drugmakers say approvals for generics likely won’t be ready when Ozempic’s market exclusivity ends in January

·Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Globe & Mail broke the news in Canada on Thursday, November 20, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Health Canada icon

Health Canada

Ozempic icon

Ozempic

Canada icon

Canada

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal